{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:47:33Z","timestamp":1786985253584,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074049"],"award-info":[{"award-number":["82074049"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.biopha.2023.115168","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T18:28:38Z","timestamp":1689272918000},"page":"115168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Cinnamic acid mitigates left ventricular hypertrophy and heart failure in part through modulating FTO-dependent N6-methyladenosine RNA modification in cardiomyocytes"],"prefix":"10.1016","volume":"165","author":[{"given":"Yimeng","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmiao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.biopha.2023.115168_bib1","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1136\/heartjnl-2021-320131","article-title":"Prevalence, incidence and survival of heart failure: a systematic review","volume":"108","author":"Emmons-Bell","year":"2022","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.biopha.2023.115168_bib2","doi-asserted-by":"crossref","first-page":"H8","DOI":"10.1152\/ajpheart.01303.2004","article-title":"Does load-induced ventricular hypertrophy progress to systolic heart failure?","volume":"289","author":"Berenji","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"16","key":"10.1016\/j.biopha.2023.115168_bib3","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.115.013894","article-title":"Inhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload","volume":"131","author":"Schiattarella","year":"2015","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.biopha.2023.115168_bib4","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1161\/CIRCRESAHA.121.318172","article-title":"Epidemiology of heart failure: a contemporary perspective","volume":"128","author":"Roger","year":"2021","journal-title":"Circ. Res"},{"issue":"3","key":"10.1016\/j.biopha.2023.115168_bib5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.biopha.2023.115168_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jep.2013.08.019","article-title":"Protective effects of cinnamic acid and cinnamic aldehyde on isoproterenol-induced acute myocardial ischemia in rats","volume":"150","author":"Song","year":"2013","journal-title":"J. Ethnopharmacol."},{"issue":"12","key":"10.1016\/j.biopha.2023.115168_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126217","article-title":"Cinnamic Acid Derivatives as Cardioprotective Agents against Oxidative and Structural Damage Induced by Doxorubicin","volume":"22","author":"Koczurkiewicz-Adamczyk","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115168_bib8","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.tiv.2018.08.010","article-title":"Glucotoxicity results in apoptosis in H9c2 cells via alteration in redox homeostasis linked mitochondrial dynamics and polyol pathway and possible reversal with cinnamic acid","volume":"53","author":"Anupama","year":"2018","journal-title":"Toxicol. Vitr."},{"issue":"12","key":"10.1016\/j.biopha.2023.115168_bib9","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1261\/rna.063503.117","article-title":"The RNA modification landscape in human disease","volume":"23","author":"Jonkhout","year":"2017","journal-title":"Rna"},{"issue":"4","key":"10.1016\/j.biopha.2023.115168_bib10","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.molcel.2019.04.025","article-title":"Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers","volume":"74","author":"Shi","year":"2019","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.biopha.2023.115168_bib11","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/CIRCULATIONAHA.118.033794","article-title":"FTO-Dependent N(6)-Methyladenosine Regulates Cardiac Function During Remodeling and Repair","volume":"139","author":"Mathiyalagan","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.biopha.2023.115168_bib12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41392-021-00699-w","article-title":"m6A demethylase FTO attenuates cardiac dysfunction by regulating glucose uptake and glycolysis in mice with pressure overload-induced heart failure","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.biopha.2023.115168_bib13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ejhf.1672","article-title":"Changes in m6A RNA methylation contribute to heart failure progression by modulating translation","volume":"22","author":"Berulava","year":"2020","journal-title":"Eur. J. Heart Fail"},{"key":"10.1016\/j.biopha.2023.115168_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.yjmcc.2012.09.002","article-title":"Mitochondria in cardiac hypertrophy and heart failure","volume":"55","author":"Rosca","year":"2013","journal-title":"J. Mol. Cell Cardiol."},{"issue":"11","key":"10.1016\/j.biopha.2023.115168_bib15","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart--an engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N. Engl. J. Med"},{"issue":"9","key":"10.1016\/j.biopha.2023.115168_bib16","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1172\/JCI120849","article-title":"Mitochondrial dysfunction in pathophysiology of heart failure","volume":"128","author":"Zhou","year":"2018","journal-title":"J. Clin. Invest"},{"issue":"5","key":"10.1016\/j.biopha.2023.115168_bib17","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10741-012-9346-7","article-title":"Alterations in mitochondrial function in cardiac hypertrophy and heart failure","volume":"18","author":"Osterholt","year":"2013","journal-title":"Heart Fail Rev."},{"key":"10.1016\/j.biopha.2023.115168_bib18","article-title":"Isolation and cryopreservation of neonatal rat cardiomyocytes","volume":"98","author":"Vandergriff","year":"2015","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.biopha.2023.115168_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105286","article-title":"DNA methylation of FTO promotes renal inflammation by enhancing m(6)A of PPAR-\u03b1 in alcohol-induced kidney injury","volume":"163","author":"Yu","year":"2021","journal-title":"Pharm. Res"},{"issue":"3","key":"10.1016\/j.biopha.2023.115168_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.122","article-title":"FTO is required for myogenesis by positively regulating mTOR-PGC-1\u03b1 pathway-mediated mitochondria biogenesis","volume":"8","author":"Wang","year":"2017","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.biopha.2023.115168_bib21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000492875","article-title":"Targeting Peroxisome Proliferator Activated Receptor \u03b1 (PPAR \u03b1) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes","volume":"49","author":"Kar","year":"2018","journal-title":"Cell Physiol. Biochem"},{"issue":"4","key":"10.1016\/j.biopha.2023.115168_bib22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cmet.2005.03.002","article-title":"Spiegelman, Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle","volume":"1","author":"Arany","year":"2005","journal-title":"Cell Metab."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2023.115168_bib23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mce.2010.05.019","article-title":"Peroxisome proliferator activated receptor alpha (PPARalpha) and PPAR gamma coactivator (PGC-1alpha) induce carnitine palmitoyltransferase IA (CPT-1A) via independent gene elements","author":"Song","year":"2010","journal-title":"Mol. Cell Endocrinol. 325("},{"issue":"13","key":"10.1016\/j.biopha.2023.115168_bib24","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/01.CIR.0000120390.68287.BB","article-title":"Hypertrophy of the heart: a new therapeutic target?","volume":"109","author":"Frey","year":"2004","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.biopha.2023.115168_bib25","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCRESAHA.110.232306","article-title":"Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure","volume":"108","author":"Dai","year":"2011","journal-title":"Circ. Res"},{"issue":"4","key":"10.1016\/j.biopha.2023.115168_bib26","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","article-title":"Expert consensus document: Mitochondrial function as a therapeutic target in heart failure","volume":"14","author":"Brown","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115168_bib27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ajhg.2009.06.002","article-title":"Loss-of-function mutation in the dioxygenase-encoding FTO gene causes severe growth retardation and multiple malformations","volume":"85","author":"Boissel","year":"2009","journal-title":"Am. J. Hum. Genet"},{"issue":"4","key":"10.1016\/j.biopha.2023.115168_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095499","article-title":"Signs of cardiac autonomic imbalance and proarrhythmic remodeling in FTO deficient mice","volume":"9","author":"Carnevali","year":"2014","journal-title":"PLoS One"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223009599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223009599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:27:01Z","timestamp":1777879621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223009599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":28,"alternative-id":["S0753332223009599"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115168","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cinnamic acid mitigates left ventricular hypertrophy and heart failure in part through modulating FTO-dependent N6-methyladenosine RNA modification in cardiomyocytes","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115168","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115168"}}